Abstract

In this work two types of biodegradable polysuccinimide-based, electrospun fibrous membranes are presented. One contains disulfide bonds exhibiting a shorter (3 days) in vivo biodegradation time, while the other one has alkyl crosslinks and a longer biodegradation time (more than 7 days). According to the mechanical measurements, the tensile strength of the membranes is comparable to those of soft the connective tissues and visceral tissues. Furthermore, the suture retention test suggests, that the membranes would withstand surgical handling and in vivo fixation. The in vivo biocompatibility study demonstrates how membranes undergo in vivo hydrolysis and by the 3rd day they become poly(aspartic acid) fibrous membranes, which can be then enzymatically degraded. After one week, the disulfide crosslinked membranes almost completely degrade, while the alkyl-chain crosslinked ones mildly lose their integrity as the surrounding tissue invades them. Histopathology revealed mild acute inflammation, which diminished to a minimal level after seven days.

Highlights

  • Polymer hydrogels are three-dimensional polymer networks that contain a large amount of aqueous solution

  • In this work we have presented the fabrication and characterization of electrospun crosslinked fibrous polysuccinimide (PSI) membranes

  • These membranes can readily hydrolyze into PASP fibrous hydrogels

Read more

Summary

Introduction

Polymer hydrogels are three-dimensional polymer networks that contain a large amount of aqueous solution. Hydrogels possess the properties of both solid and liquid materials: they can maintain their shape as solids do, yet small molecules for example drugs, can migrate through them by diffusion (as they would do in fluids). Due to their high water content, they resemble the mammalian soft tissues, hydrogels are commonly used in clinical practice and experimental medicine in a wide range of applications including diagnostics, drug delivery, regenerative medicine [1,2,3,4,5]. Innovation and Technology in Hungary, within the framework of the Therapeutic Development thematic programme of the Semmelweis University and by EFOP-3.6.3-VEKOP-16-201700009

Objectives
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call